Terms: = Germ cell tumor AND NRAS, N-ras, 4893, ENSG00000213281, P01111, NRAS1 AND Staging
13 results:
1. [Clinicopathological features and prognosis of anorectal melanoma: A report of 68 cases].
Lai YM; Li ZW; Li H; Wu Y; Shi YF; Zhou LX; Lou YT; Cui CL
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):262-269. PubMed ID: 37042136
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic model for patient survival in primary anorectal mucosal melanoma: stage at presentation determines relevance of histopathologic features.
Nagarajan P; Piao J; Ning J; Noordenbos LE; Curry JL; Torres-Cabala CA; Diwan AH; Ivan D; Aung PP; Ross MI; Royal RE; Wargo JA; Wang WL; Samdani R; Lazar AJ; Rashid A; Davies MA; Prieto VG; Gershenwald JE; Tetzlaff MT
Mod Pathol; 2020 Mar; 33(3):496-513. PubMed ID: 31383963
[TBL] [Abstract] [Full Text] [Related]
3. Predictive genetic profiles for regional lymph node metastasis in primary cutaneous melanoma: a case-matched pilot study.
Nye A; Collins JD; Porter CL; Montes de Oca M; George K; Stafford CG; Schammel CMG; Horton S; Trocha SD
Melanoma Res; 2018 Dec; 28(6):555-561. PubMed ID: 30179987
[TBL] [Abstract] [Full Text] [Related]
4. [Diagnostics of malignant melanoma of the skin : Recommendations of the current S3 guidelines on histology and molecular pathology].
Rose C
Hautarzt; 2017 Sep; 68(9):749-761. PubMed ID: 28875289
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic factors and treatment outcomes in 444 patients with mucosal melanoma.
Heppt MV; Roesch A; Weide B; Gutzmer R; Meier F; Loquai C; Kähler KC; Gesierich A; Meissner M; von Bubnoff D; Göppner D; Schlaak M; Pföhler C; Utikal J; Heinzerling L; Cosgarea I; Engel J; Eckel R; Martens A; Mirlach L; Satzger I; Schubert-Fritschle G; Tietze JK; Berking C
Eur J Cancer; 2017 Aug; 81():36-44. PubMed ID: 28600969
[TBL] [Abstract] [Full Text] [Related]
6. [Diagnostics of malignant melanoma of the skin : Recommendations of the current S3 guidelines on histology and molecular pathology].
Rose C
Pathologe; 2017 Feb; 38(1):49-61. PubMed ID: 28154916
[TBL] [Abstract] [Full Text] [Related]
7. Primary malignant melanoma of the breast: case report and review of the literature.
Drueppel D; Schultheis B; Solass W; Ergonenc H; Tempfer CB
Anticancer Res; 2015 Mar; 35(3):1709-13. PubMed ID: 25750332
[TBL] [Abstract] [Full Text] [Related]
8. BRAF mutation status is an independent prognostic factor for resected stage IIIB and IIIC melanoma: implications for melanoma staging and adjuvant therapy.
Barbour AP; Tang YH; Armour N; Dutton-Regester K; Krause L; Loffler KA; Lambie D; Burmeister B; Thomas J; Smithers BM; Hayward NK
Eur J Cancer; 2014 Oct; 50(15):2668-76. PubMed ID: 25070294
[TBL] [Abstract] [Full Text] [Related]
9. Malignant melanoma S3-guideline "diagnosis, therapy and follow-up of melanoma".
Pflugfelder A; Kochs C; Blum A; Capellaro M; Czeschik C; Dettenborn T; Dill D; Dippel E; Eigentler T; Feyer P; Follmann M; Frerich B; Ganten MK; Gärtner J; Gutzmer R; Hassel J; Hauschild A; Hohenberger P; Hübner J; Kaatz M; Kleeberg UR; Kölbl O; Kortmann RD; Krause-Bergmann A; Kurschat P; Leiter U; Link H; Loquai C; Löser C; Mackensen A; Meier F; Mohr P; Möhrle M; Nashan D; Reske S; Rose C; Sander C; Satzger I; Schiller M; Schlemmer HP; Strittmatter G; Sunderkötter C; Swoboda L; Trefzer U; Voltz R; Vordermark D; Weichenthal M; Werner A; Wesselmann S; Weyergraf AJ; Wick W; Garbe C; Schadendorf D; ;
J Dtsch Dermatol Ges; 2013 Aug; 11 Suppl 6():1-116, 1-126. PubMed ID: 24028775
[TBL] [Abstract] [Full Text] [Related]
10. MicroRNA and cutaneous melanoma: from discovery to prognosis and therapy.
Segura MF; Greenwald HS; Hanniford D; Osman I; Hernando E
Carcinogenesis; 2012 Oct; 33(10):1823-32. PubMed ID: 22693259
[TBL] [Abstract] [Full Text] [Related]
11. Clinical correlates of nras and BRAF mutations in primary human melanoma.
Ellerhorst JA; Greene VR; Ekmekcioglu S; Warneke CL; Johnson MM; Cooke CP; Wang LE; Prieto VG; Gershenwald JE; Wei Q; Grimm EA
Clin Cancer Res; 2011 Jan; 17(2):229-35. PubMed ID: 20975100
[TBL] [Abstract] [Full Text] [Related]
12. Targeting X-linked inhibitor of apoptosis protein to increase the efficacy of endoplasmic reticulum stress-induced apoptosis for melanoma therapy.
Hiscutt EL; Hill DS; Martin S; Kerr R; Harbottle A; Birch-Machin M; Redfern CP; Fulda S; Armstrong JL; Lovat PE
J Invest Dermatol; 2010 Sep; 130(9):2250-8. PubMed ID: 20520630
[TBL] [Abstract] [Full Text] [Related]
13. Thyroid carcinoma.
Gillenwater AM; Weber RS
Cancer Treat Res; 1997; 90():149-69. PubMed ID: 9367082
[TBL] [Abstract] [Full Text] [Related]
